Phase Ⅱ Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Venous Leg

NARecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

March 31, 2027

Conditions
Venous Leg Ulcer
Interventions
OTHER

stem cell preparation combined with silver ion dressing

The dosage range of each cm2 ulcer wound is (1~5)×10\^6. The dosage of human umbilical cord mesenchymal stem cells for the second treatment is determined according to the severity of the ulcer. Each patient is treated for 2 consecutive times, and the interval between each treatment is 3 days.

PROCEDURE

silver ion dressing

fter wound debridement, a silver ion dressing suitable for the size of the wound was cut and covered on the wound bed. Sterile gauze was covered on the silver ion dressing and fixed with adhesive tape.

Trial Locations (1)

400038

RECRUITING

Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing

All Listed Sponsors
lead

ShiCang Yu

OTHER